Tätigkeitsbereich:Forschung & Entwicklung incl. Design Fachabteilung:Vehicle Components & Tech Center China Gesellschaft:Mercedes-Benz Group China Ltd. Standort:Mercedes-Benz Group China Ltd., Beijing Startdatum:06.07.2026 Veröffentlichungsdatum:02.07.2026 Stellennummer:MER00044ZK Arbeitszeit:Vollzeit Bewerben Aufgaben Objective: Responsible for FMU-based simulation test bench development and virtual
Title: Commissioning Editor - Collections Management and Acquisition Location: Beijing, Shanghai, Nanjing, China - hybrid working model Application Deadline: August 7, 2026 About Springer Nature Springer Nature is one of the leading publishers of research in the
At ABB, we help industries run leaner and cleaner—and every person here makes that happen. You’ll be empowered to lead, supported to grow, and proud of the impact we create together. Join us and help run
Description What we are looking for We are looking for an excellent CMD Field Service Engineer who can independently solve client problems, who will be responsible for the operation of the relevant customers machine and report
About the job Sanofi has decided to invest into a new large state-of-the art facility for Insulin Drug Substance in Beijing, China. For this green field operation, we’re enhancing our legacy of excellence and build on
About the job Sanofi has decided to invest into a new large state-of-the art facility for Insulin Drug Substance in Beijing, China. For this green field operation, we’re enhancing our legacy of excellence and build on
About the job Sanofi has decided to invest into a new large state-of-the art facility for Insulin Drug Substance in Beijing, China. For this green field operation, we’re enhancing our legacy of excellence and build on
About the job Sanofi has decided to invest into a new large state-of-the art facility for Insulin Drug Substance in Beijing, China. For this green field operation, we’re enhancing our legacy of excellence and build on
About the job Sanofi has decided to invest into a new large state-of-the art facility for Insulin Drug Substance in Beijing, China. For this green field operation, we’re enhancing our legacy of excellence and build on
About the job Sanofi has decided to invest into a new large state-of-the art facility for Insulin Drug Substance in Beijing, China. For this green field operation, we’re enhancing our legacy of excellence and build on
Job Description: We believe in bold ideas, diverse perspectives, and the drive to transform knowledge into impact. Here, your curiosity fuels progress, your voice shapes innovation, and your ambition helps redefine what’s possible within science and
Job Title: Research Integrity Manager Location: Beijing, Shanghai or Nanjing, China Application Deadline: 31st July 2026 About Springer Nature Springer Nature is one of the leading publishers of research in the world. We publish the largest
Job Title: Research Integrity Specialist Location: Beijing, Shanghai, Nanjing or London – hybrid working model Application Deadline: July 31st, 2026 About Springer Nature Springer Nature is one of the leading publishers of research in the world.
Job Title: Research Integrity Adviser Location: Beijing, Shanghai or Nanjing, China About Springer Nature Springer Nature is one of the leading publishers of research in the world. We publish the largest number of journals and books
Company Description 特纳唐逊（Turner & Townsend）是一家全球性专业服务企业，业务遍布60多个国家，拥有22,000余名专业人才。我们服务于房地产、基础设施、能源及自然资源等领域客户，携手共创价值，以优质项目成果改善人们生活。凭借深度协同与专业能力，我们成功落地全球极具影响力的各类项目，化挑战为机遇，化复杂为成功。 公司核心服务涵盖：项目与计划管理、成本管理、资产管理、商务管理、管控与绩效、采购与供应链、净零低碳及数字化解决方案。 特纳唐逊由全球领先的商业地产服务与投资集团——世邦魏理仕（CBRE Group, Inc.）进行了战略投资，双方结成全球合作伙伴关系。我们强强联合，为全球客户提供顶尖的项目及成本管理服务。 欢迎访问官网了解更多：www.turnerandtownsend.com Turner & Townsend is a global professional services company with over 22,000 people in more than 60 countries. Working with our clients across real estate, infrastructure,
At ABB, we help industries run leaner and cleaner—and every person here makes that happen. You’ll be empowered to lead, supported to grow, and proud of the impact we create together. Join us and help run
Background Sanofi has decided to invest in new, state-of-the-art production facilities for the entire insulin portfolio as part of the InsuLINK program, to ensure a future-oriented, sustainable, and reliable long-term supply for diabetes patients worldwide. Beijing,
Background Sanofi has decided to invest in new, state-of-the-art production facilities for the entire insulin portfolio as part of the InsuLINK program, to ensure a future-oriented, sustainable, and reliable long-term supply for diabetes patients worldwide. Beijing,
Background Sanofi has decided to invest in new, state-of-the-art production facilities for the entire insulin portfolio as part of the InsuLINK program, to ensure a future-oriented, sustainable, and reliable long-term supply for diabetes patients worldwide. Beijing,
Background Sanofi has decided to invest in new, state-of-the-art production facilities for the entire insulin portfolio as part of the InsuLINK program, to ensure a future-oriented, sustainable, and reliable long-term supply for diabetes patients worldwide. Beijing,